1

Trends This Week – Junk News in the Media – 09.06.17

Download this episode (right click and save) In this episode of Trends This Week, Gerald Celente discusses the prominence of junk news in the media.  Real stories fail to make the headlines, yet CNN breaks the news of Hillary Clinton’s memoir.  All while the blatant failures of the United States Military are swept under the rug.  

1

A Just Cause Radio – Pharmaceutical Companies are Abusing America’s Most Vulnerable – 07.23.17

The host Cliff Stewart, Lisa Stewart and Lamont Banks our AJC Radio Hosts will be discussing and giving their insight on tonight’s topic with our Special Guest Dr. John Abramson, who from 2005 through the present has served as an expert in litigation involving prescription drugs and medical devices, giving him access to literally millions of pages of confidential corporate documents and unreleased …

1

Lauren McCauley – Fears Grow that Rule of Trump Will Suppress Rule of Law Under Sessions

Updated 2pm EDT: Democrats on the Senate Judiciary Committee invoked a procedural move called the two-hour rule—which, according to The Hill, prevents “holding committee meetings beyond the first two hours of the Senate’s day”—to push the attorney general vote until Wednesday. The move stalls the controversial confirmation of Sen. Jeff Sessions and came at the same time that Democrats on …

1

A Just Cause – Shining a Spotlight on Capitol Hill & U.S. Senator Dianne Feinstein – 01.29.17

The host Cliff Stewart, Lisa Stewart and Lamont Banks will be Shining a Spotlight on Capitol Hill and United States Senator of California Dianne Feinstein, who has built a reputation as an independent voice, working with both Democrats and Republicans to find commonsense solutions to the problems facing California and the nation.

1

Leid Stories—The Trump Card vs the Clintons and The Clinton Foundation: How Will They Fare?—01.24.17

They’ve kept a low profile since the Electoral College declared Donald Trump the winner of the contentious 2016 presidential election, but Bill and Hillary Clinton were among the high-level contingent of former U.S. presidents and their wives witnessing Trump’s inauguration on Jan. 20.

1

Leid Stories—Confirmation Hearings for Trump’s Cabinet Nominees Begin—01.10.17

Confirmation hearings for President-elect Donald Trump’s nominees for Cabinet-level posts begin today. Sen. Jeff Sessions (R-Ala.) faces off with the Senate Judiciary Committee at 9 a.m., and the Senate Homeland Security Committee questions retired Marine general John Kelly at 3 p.m.

1

Leid Stories—Reckoning with the System: How Far Along Are You, and Where Are You Headed?—11.15.16

It’s a week since Republicans captured not only the White House, the House of Representatives and the U.S. Senate, but 32 state legislatures and 33 governorships as well. By any definition it’s a political drubbing—and, as most believe, a dramatic political turning point for the country. The writing’s on the wall.

1

Stop Paying Executives for Performance

For chief executives and other senior leaders, it is not unusual for 60-80% of their pay to be tied to performance – whether performance is measured by quarterly earnings, stock prices, or something else. And yet from a review of the research on incentives and motivation, it is wholly unclear why such a large proportion of these executives’ compensation packages …

1

A Just Cause – Spotlight on Capitol Hill & Congressman John Conyers Jr – 01.31.16

The host Cliff Stewart, Lisa Stewart and Lamont Banks will be shining a Spotlight on Congressman John Conyers Jr., who in November 2014 was elected to his 26th consecutive term, making him the first African-American to hold the distinction as Dean (most senior member) of Congress.

1

Mike Mariani – How the American opiate epidemic was started by one pharmaceutical company

The state of Kentucky may finally get its deliverance. After more than seven years of battling the evasive legal tactics of Purdue Pharma, 2015 may be the year that Kentucky and its attorney general, Jack Conway, are able to move forward with a civil lawsuit alleging that the drugmaker misled doctors and patients about their blockbuster pain pill OxyContin, leading …